These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22207024)

  • 1. Emervel®: full-face rejuvenation with a range of customized hyaluronic acid fillers.
    Rzany B
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s4. PubMed ID: 22207024
    [No Abstract]   [Full Text] [Related]  

  • 2. The Emervel French survey: a prospective real-practice descriptive study of 1,822 patients treated for facial rejuvenation with a new hyaluronic acid filler.
    Farhi D; Trevidic P; Kestemont P; Boineau D; Cartier H; Bodokh I; Brun P; Ascher B; Savary J;
    J Drugs Dermatol; 2013 May; 12(5):e88-93. PubMed ID: 23652965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal rejuvenation with fillers: global faceculpture approach.
    Raspaldo H
    Dermatol Surg; 2012 Feb; 38(2):261-5. PubMed ID: 22122524
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronic acid fillers.
    Monheit GD; Coleman KM
    Dermatol Ther; 2006; 19(3):141-50. PubMed ID: 16784513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips.
    Cartier H; Trevidic P; Rzany B; Sattler G; Kestemont P; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s17-26. PubMed ID: 22497040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid fillers for the male patient.
    Monheit GD; Prather CL
    Dermatol Ther; 2007; 20(6):394-406. PubMed ID: 18093013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months.
    Rzany B; Cartier H; Kestemont P; Trevidic P; Sattler G; Kerrouche N; Dhuin JC; Ma YM
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1153-61. PubMed ID: 22759252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid fillers in facial rejuvenation.
    Lupo MP
    Semin Cutan Med Surg; 2006 Sep; 25(3):122-6. PubMed ID: 17055390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in face rejuvenation by hyaluronic acid injections.
    Andre P
    J Cosmet Dermatol; 2008 Dec; 7(4):251-8. PubMed ID: 19146600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fillers.
    Rzany B; Cartier H; Kestermont P; Trevidic P; Sattler G; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s27-34. PubMed ID: 22497041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short review on face rejuvenation procedures: focus on preoperative antiseptic and anesthetic delivery by JetPeel™-3 (a high pressure oxygen delivery device).
    Iannitti T; Capone S; Palmieri B
    Minerva Chir; 2011 Jun; 66(3 Suppl 1):1-8. PubMed ID: 21971508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers.
    Nanda S; Bansal S
    Indian J Dermatol Venereol Leprol; 2013; 79(1):32-40. PubMed ID: 23254727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable hyaluronic acid fillers for periorbital rejuvenation.
    Lee S; Yen MT
    Int Ophthalmol Clin; 2013; 53(3):1-9. PubMed ID: 23751427
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvéderm: a hyaluronic acid dermal filler.
    Monheit GD; Prather CL
    J Drugs Dermatol; 2007 Nov; 6(11):1091-5. PubMed ID: 18038495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection techniques for revolumization of the perioral region with hyaluronic acid.
    Weinkle S
    J Drugs Dermatol; 2010 Apr; 9(4):367-71. PubMed ID: 20514794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel facial rejuvenation treatment using pneumatic injection of non-cross-linked hyaluronic acid and hypertonic glucose solution.
    Mashiko T; Abo Y; Kuno S; Yoshimura K
    Dermatol Surg; 2015 Jun; 41(6):755-8. PubMed ID: 25973564
    [No Abstract]   [Full Text] [Related]  

  • 20. Fillers and neocollagenesis.
    Carruthers JD; Carruthers JA; Humphrey S
    Dermatol Surg; 2014 Dec; 40 Suppl 12():S134-6. PubMed ID: 25417563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.